The reason for this might be that the included COVID-19 patients were not in the crucial, initial stage of the disease and in fact, it has been shown that during days 0–3 of SARS-CoV-2 infection, the classical RAS, as represented by angiotensin II, is dramatically upregulated in severe COVID-19 [28]. The gene discussed is AGT; the disease is COVID-19.